Vaishali Pharma Q2 Results
- BSE: -
- NSE: VAISHALI
- ISIN: INE972X01022
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
6.11
-0.07 (-1.13%)
-0.07 (-1.13%)Volume6.20 L
Updated: Fri 10 Apr, 2026 | 15:51:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Vaishali Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 32.23 | 22.52 | 43.10% | 18.49 | 74.32% |
| Depreciation/ Amortization | 0.17 | 0.14 | 21.27% | 0.12 | 41.38% |
| Operating Income | 1.22 | 1.23 | -0.60% | 2.30 | -47.00% |
| Net Income | 1.18 | 1.28 | -7.40% | 1.97 | -39.82% |
| Other Operating Expenses Total | 1.73 | 1.56 | 10.53% | 0.94 | 83.85% |
| Net Income Before Taxes | 1.66 | 1.74 | -4.56% | 2.63 | -37.03% |
| Total Revenue | 33.45 | 23.75 | 40.84% | 20.79 | 60.91% |
| Selling/ General/ Admin Expenses Total | 0.63 | 0.78 | -19.48% | 0.62 | 1.38% |
| Diluted Normalized EPS | 0.49 | 0.10 | 390.00% | 0.15 | 224.50% |